
News – Page 10
-
Johnson & Johnson Settles 1,000 Talc Lawsuits for $100MAfter a seven-month lull due to COVID-19, talcum powder litigation is back in the news and in a big way.
-
FDA Approves First New Mesothelioma Treatment in 16 YearsOn Oct. 2, 2020, the Food and Drug Administration announced it had approved Bristol-Myers Squibb’s Opdivo (nivolumab) in combination with Yervoy (ipilimumab)…Michelle Llamas, BCPA October 6, 2020
-
FDA Issues Guidance to Control NDMA in Zantac, Other DrugsThe Food and Drug Administration has issued guidance for drugmakers on how to detect and prevent potential cancer-causing nitrosamine contamination in drugs. …Michelle Llamas, BCPA October 6, 2020
-
Association of Marketing and Communication Professionals Recognizes Drugwatch in Awards SpotlightThe Association of Marketing and Communication Professionals has honored Drugwatch for its consequential reporting on the vaping industry’s marketing practices.Emily Miller October 5, 2020
-
Elmiron & Vision Problems Lawsuits: A Q&A with Trial Attorney Trent MiracleElmiron, or pentosan polysulfate sodium, is the only oral medication approved by the U.S. Food and Drug Administration to treat…Michelle Llamas, BCPA September 25, 2020
-
COVID-19 and Vaping: A Q&A with Stanford Professor Bonnie Halpern-FelsherIn recent years, e-cigarette use among adolescents has skyrocketed. Some have even called it an epidemic. Between 2017 and 2018…Michelle Llamas, BCPA September 15, 2020
-
Drugwatch Writer Helps Secure Funding for National COVID-19 TeleconferenceDrugwatch Senior Writer Michelle Llamas helped the National Center for Health Research obtain funding for its Covid…Emily Miller September 1, 2020
-
Presidential Election 2020: Health Care and Drug PricesThe 2020 presidential election on Nov. 3 is quickly approaching, and Drugwatch researched President Donald J. Trump and former Vice President Joe…Michelle Llamas, BCPA August 24, 2020
-
Thousands of Infusion Pumps Recalled After Several Injuries and a DeathOn March 6, 2020, the U.S. Food and Drug Administration announced that it had classified the Becton Dickinson Alaris System infusion pump recall…Michelle Llamas, BCPA August 3, 2020
Who Am I Calling?
Calling this number connects you with a Drugwatch representative. We will direct you to one of our trusted legal partners for a free case review.
Drugwatch's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.
(888) 645-1617